03/11/2005
Fast-track guidance for life-saving drugs
Patients should be able to receive life-saving drugs more quickly under a new scheme announced by the government.
Health Secretary Patricia Hewitt announced proposals to allow the National Institute for Health and Clinical Excellence to produce faster guidance on life-saving drugs.
The proposals would allow NICE to produce faster guidance on certain drugs, which had already been licensed and new medicines referred to NICE, meaning that drugs could be assessed within eight weeks of licensing.
NICE is conducting a three-month consultation on the proposals. However, the first five drugs to benefit from the fast-track service have already been identified. They include one treatment for non-Hodgkin’s lymphoma and another for multiple myeloma, as well as three breast cancer drugs, including Herceptin. Herceptin has caused controversy, because it is only currently available for patients with advanced breast cancer, but not for those in the early stages of the disease.
The first guidance is expected next June.
The system will only be used for certain drugs, with all others being assessed under the current system.
Health Minister Jane Kennedy said: “This new guidance will benefit many thousands of patients, especially those with life threatening conditions and will provide greater certainty about the provision of important new treatments.”
However, Liberal Democrat Health Spokesperson Steve Webb said: "The government has at last responded to our calls for a swifter process for approving new drugs for the NHS. But with more and more new drugs being developed, NICE is being asked to do more work. Meanwhile its funding has actually been cut by this government. Ministers must guarantee that NICE will have the cash to implement this new faster process.
(KMcA/SP)
Health Secretary Patricia Hewitt announced proposals to allow the National Institute for Health and Clinical Excellence to produce faster guidance on life-saving drugs.
The proposals would allow NICE to produce faster guidance on certain drugs, which had already been licensed and new medicines referred to NICE, meaning that drugs could be assessed within eight weeks of licensing.
NICE is conducting a three-month consultation on the proposals. However, the first five drugs to benefit from the fast-track service have already been identified. They include one treatment for non-Hodgkin’s lymphoma and another for multiple myeloma, as well as three breast cancer drugs, including Herceptin. Herceptin has caused controversy, because it is only currently available for patients with advanced breast cancer, but not for those in the early stages of the disease.
The first guidance is expected next June.
The system will only be used for certain drugs, with all others being assessed under the current system.
Health Minister Jane Kennedy said: “This new guidance will benefit many thousands of patients, especially those with life threatening conditions and will provide greater certainty about the provision of important new treatments.”
However, Liberal Democrat Health Spokesperson Steve Webb said: "The government has at last responded to our calls for a swifter process for approving new drugs for the NHS. But with more and more new drugs being developed, NICE is being asked to do more work. Meanwhile its funding has actually been cut by this government. Ministers must guarantee that NICE will have the cash to implement this new faster process.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
01 March 2005
Alzheimer's drugs could be withdrawn
The National Institute of Clinical Excellence (NICE) has recommended the withdrawal of three drugs frequently used to help treat the symptoms of Alzheimer's disease.
Alzheimer's drugs could be withdrawn
The National Institute of Clinical Excellence (NICE) has recommended the withdrawal of three drugs frequently used to help treat the symptoms of Alzheimer's disease.
29 May 2015
23 Charged With Drug Offences Following Raids
More than 20 people have been charged with drug offences following a number of raids carried out in London, Gravesend, Dover and Deal. A total of 23 people were arrested during twenty raids carried out over three days. The suspects, ranging in age from 17 to 52, have all been charged in connection with the supply of class A drugs.
23 Charged With Drug Offences Following Raids
More than 20 people have been charged with drug offences following a number of raids carried out in London, Gravesend, Dover and Deal. A total of 23 people were arrested during twenty raids carried out over three days. The suspects, ranging in age from 17 to 52, have all been charged in connection with the supply of class A drugs.
07 September 2009
Brixton Drug Gang Get Long Sentences
A gang of criminals who ran a lucrative drug dealing network from a car tyre shop in Brixton were sentenced last week to a total of 81 years in prison. Nine men, who were previously convicted of conspiracy to supply class A drugs, appeared at Kingston Crown Court today to hear their sentences.
Brixton Drug Gang Get Long Sentences
A gang of criminals who ran a lucrative drug dealing network from a car tyre shop in Brixton were sentenced last week to a total of 81 years in prison. Nine men, who were previously convicted of conspiracy to supply class A drugs, appeared at Kingston Crown Court today to hear their sentences.
23 January 2006
Anger over Alzheimer's drugs ruling
The revised guidance on drugs for the treatment of Alzheimer's disease has been greeted with anger by Alzheimer's charities.
Anger over Alzheimer's drugs ruling
The revised guidance on drugs for the treatment of Alzheimer's disease has been greeted with anger by Alzheimer's charities.
10 August 2007
Court Orders Review Of Alzheimer's Guidelines
A high court judge has ordered a review of guidelines on the way it decides which Alzheimer's patients are given three drugs to treat the brain-destroying disease.
Court Orders Review Of Alzheimer's Guidelines
A high court judge has ordered a review of guidelines on the way it decides which Alzheimer's patients are given three drugs to treat the brain-destroying disease.